Quinnova Pharmaceuticals, Inc. is a specialty pharmaceutical company founded on innovative, patent-protected dermal delivery technologies. They utilize three independent proprietary technology platforms to address a wide variety of skin and wound disorders. AmDerma, LLC acquired Quinnova in December 2010.
For more information visit:
For more information visit:
Employees: 51-200
Founded date: 2003
Investors 3
| Date | Name | Website |
| - | H.I.G. Cap... | higcapital... |
| - | H.I.G. Bio... | higbio.com |
| - | H.I.G. Cap... | hig.com/ |
Mentions in press and media 1
| Date | Title | Description |
| 28.10.2009 | Quinnova Pharmaceuticals Completes $17.4M Series B Financing Round | Quinnova Pharmaceuticals, Inc., completed a $17.4m Series B financing round led by Safeguard Scientifics, Inc. (NYSE:SFE), with participation from existing investors Thomas, McNerney & Partners and H.I.G. BioVentures. Founded in 2005 an... |